Koers Epirus Biopharmaceuticals Inc Nasdaq
Aandelen
US29428P1075
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 0 0 | Omzet 2015 | 0,7 0,66 | Marktkapitalisatie | 75,33 mln. 70,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -41 mln. -38,31 mln. | Nettowinst (verlies) 2015 | -52 mln. -48,59 mln. | EV/omzet 2014 | 14.770.294.750 x |
Nettoliquiditeiten 2014 | 14,18 mln. 13,25 mln. | Nettoliquiditeiten 2015 | 16,68 mln. 15,59 mln. | EV/omzet 2015 | 83.658.631 x |
K/w-verhouding 2014 |
-0,83
x | K/w-verhouding 2015 |
-1,35
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,13% | 46,93 mld. | |
+37,72% | 39,08 mld. | |
-8,73% | 38,48 mld. | |
+28,09% | 31,01 mld. | |
-12,26% | 26,14 mld. | |
+10,57% | 25,88 mld. | |
+45,05% | 14,15 mld. | |
+32,23% | 12,53 mld. | |
-6,56% | 11,36 mld. |